Closed daily for lunch 11:30 AM - 12:30 PM.
Jody Houston, M.D.
Nishita Kara, M.D.
Stephen Lacey, M.D.
David Levitan, M.D.
Timothy Ritter, M.D.
Senior Medical Research Director
Jeffrey Smith, M.D.
David Spady, M.D.
Karen Steffer, M.D.
James Weber, M.D.
Kanthi Yalamanchili, M.D.
Melissa Bachman, P.A.
Betsy Dodson, P.A.
Nancy Farrar, P.A.
Heather Johnston-Chambers, N.P.
Heather Kline, N.P.
Carrie Cole Seale, MSW
Behavioral Health Specialist
Mazyar Malakouti, M.D.
Brent W. Lacey, M.D.
Brooke Hodnick, P.A.
Mona Dave, M.D.
What is Fatty Liver (Steatosis) or Scarring of the Liver (Cirrhosis)?
The function of the liver is to turn nutrients into chemicals your body needs. It filters out poisons. It helps turn food into energy. So, when the liver isn’t working well, it can affect your whole body.
NAFLD or nonalcoholic fatty liver disease is when too much fat builds up inside the cells of the liver, and results in inflamation of the liver tissue. One form of NAFLD is nonalcoholic steatohepatitis (NASH), an aggressive form of fatty liver disease, which is marked by liver inflammation and may progress to advanced scarring (cirrhosis) and liver failure. Between 5%-12% of people with NASH will progress to cirrhosis.
Cirrhosis is the most advanced form of scarring, in which the healthy liver tissues are slowly replaced by scar tissues. When increased scarring replaces the healthy parts of the liver, it makes it difficult for the liver to function property and can result in complete liver failure.
What is FibroScan® Test and why do I need it?
FibroScan® is a proven technology used for noninvasive examinations of the liver. It works by emitting a small pulse of energy, called a shear wave, which then calculates the speed of this energy as it travels through the liver and translates that speed with two scores that a gastroenterologist will use to determine the overall health of your liver.
FibroScan® is superior to ultrasound for the detection of liver scarring and therefore may be used to determine if cirrhosis or advanced fibrosis is present at the initial assessment and whether it has developed during follow up because of disease progression. This information is then used by a gastroenterologist to individualize and optimize your treatment plan.
Most patients with chronic liver disease can be assessed with FibroScan®. However, FibroScan® is not recommended for any patient that is/has:
The Benefits of FibroScan
Factors that can Increase Risk of Fatty Liver/Cirrhosis
Signs/Symptoms of Fatty Liver/Cirrhosis
Most Fatty Liver has no symptoms, but Advanced Disease may have: